Cell-free DNA concentration as a prognostic biomarker in patients with non-small cell lung cancer under immunotherapy treatment

被引：0
|
作者：
Barragan, Isabel
Perez-Ruiz, Elisabeth
Onieva, Juan Luis
Garrido-Ramos, Maria
Martinez-Galvez, Beatriz
Dubbelman, Jaime
Alba, Emilio
Zafra, Juan
Cobo, Manuel
Oliver, Javier
Rueda-Dominguez, Antonio
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-1044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1044
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms
    Barnet, Megan B.
    Cooper, Wendy A.
    Boyer, Michael J.
    Kao, Steven
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (06)
  • [32] Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy
    Rocco, Danilo
    Della Gravara, Luigi
    Ragone, Angela
    Sapio, Luigi
    Naviglio, Silvio
    Gridelli, Cesare
    CANCERS, 2023, 15 (19)
  • [33] Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients
    Florian Janke
    Arlou Kristina Angeles
    Anja Lisa Riediger
    Simone Bauer
    Martin Reck
    Albrecht Stenzinger
    Marc A. Schneider
    Thomas Muley
    Michael Thomas
    Petros Christopoulos
    Holger Sültmann
    Clinical Epigenetics, 2022, 14
  • [34] Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-free DNA in Patients With Non-Small Cell Lung Cancer
    Lee, Kirsty W. C.
    Li, Molly S. C.
    Gai, Wanxia
    Lau, Yat Ming
    Chan, Allen K. C.
    Chan, Oscar S. H.
    Lee, Chee Khoon
    Yeung, Rebecca M. W.
    Fung, Sherwood Y. H.
    Cheung, Wai F. F.
    Chan, Vivian W. W.
    Leung, Linda
    Kam, Kenny N. P.
    Mok, Tony S. K.
    JAMA ONCOLOGY, 2023, 9 (02) : 261 - 265
  • [35] Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients
    Janke, Florian
    Angeles, Arlou Kristina
    Riediger, Anja Lisa
    Bauer, Simone
    Reck, Martin
    Stenzinger, Albrecht
    Schneider, Marc A.
    Muley, Thomas
    Thomas, Michael
    Christopoulos, Petros
    Sueltmann, Holger
    CLINICAL EPIGENETICS, 2022, 14 (01)
  • [36] Preoperative plateletcrit is a Prognostic Biomarker for Survival in Patients with Non-Small Cell Lung Cancer
    Hur, Joon Young
    Lee, Ha Yeon
    Chang, Hye Jung
    Choi, Cheon Woong
    Kim, Dae Hyun
    Eo, Wan Kyu
    JOURNAL OF CANCER, 2020, 11 (10): : 2800 - 2807
  • [37] Correlation between cell-free DNA and survival in patients receiving Nivolumab for advanced non-small cell lung cancer
    Rijavec, E.
    Biello, F.
    Alama, A.
    Dal Bello, M. G.
    Coco, S.
    Vanni, I.
    Genova, C.
    Barletta, G.
    Rossi, G.
    Maggioni, C.
    Gaitan, N. S. D.
    Distefano, R.
    Tagliamento, M.
    Merlo, D. F.
    Grossi, F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 160 - 160
  • [38] Plasma cell-free DNA integrity analyses for ovarian and non-small cell lung cancer patients with peptide vaccination
    Waki, Kayoko
    Yamada, Akira
    CANCER SCIENCE, 2018, 109 : 1273 - 1273
  • [39] Integrity of circulating cell-free DNA as a prognostic biomarker for vaccine therapy in patients with nonsmall cell lung cancer
    Waki, Kayoko
    Yokomizo, Kanako
    Yoshiyama, Koichi
    Takamori, Shinzo
    Komatsu, Nobukazu
    Yamada, Akira
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2021, 43 (02) : 176 - 182
  • [40] Advances in the Treatment of Non-Small Cell Lung Cancer: Immunotherapy
    Patel, Shetal A.
    Weiss, Jared
    CLINICS IN CHEST MEDICINE, 2020, 41 (02) : 237 - +
12345